Individualized rTMS for Motor Recovery in Stroke Patients

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Jun 13, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called individualized repetitive Transcranial Magnetic Stimulation (rTMS) to help improve movement in stroke patients. The goal is to see how effective this treatment is for helping patients recover their motor skills and increase brain activity after experiencing a stroke. The study is currently looking for participants who are at least 20 years old and had a stroke within the last three months. Eligible individuals should have a stroke that affects only one side of the body and be able to sit for at least 15 minutes.

Participants in the trial will receive tailored rTMS treatments to help their recovery. However, some people may not be eligible to join, such as those with a history of certain neurological diseases, previous strokes, or conditions like seizures and pregnancy. If you or a loved one is interested in improving motor function after a stroke and meets the eligibility criteria, this trial might be a good opportunity to explore.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Unilateral ischemic or hemorrhagic stroke
• • 2. Stroke within 3 months
• • 3. Medical Research Council Scale for Muscle Strength in upper limb ≤ 3
• • 4. No previous stroke, seizure, dementia, Parkinson's disease or other degenerative neurological diseases.
• • 5. Patient could sit over 15 minutes
• • 6. Age over 20
• Exclusion Criteria:
• • 1. Previous stroke, traumatic brain injury, brain tumor
• • 2. With central nervous system disease (spinal cord injury, Parkinson's disease)
• • 3. Any contraindication to rTMS (seizure, alcoholism, metal implant, pacemaker)
• • 4. Patients unable to cooperate the treatment
• • 5. Pregnancy
• • 6. Depression